Viral Vector And Plasmid Dna Manufacturing Market Size And Share

  • Report Code : TIPRE00003074
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 140
Buy Now

Viral Vector and Plasmid DNA Manufacturing Market Size, Segments, and Trends by 2027

Buy Now

Viral Vector and Plasmid DNA Manufacturing Market Report Viral Vector and Plasmid DNA Manufacturing Market Scope and Analysis Viral Vector and Plasmid DNA Manufacturing Market Size and Share

Viral Vector and Plasmid DNA Manufacturing Market: Strategic Insights

Viral Vector and Plasmid DNA Manufacturing Market

  • CAGR (2019 - 2027)
    22.1%
  • Market Size 2019
    US$ 459.4 Million
  • Market Size 2027
    US$ 2,247.7 Million

Market Dynamics

GROWTH DRIVERS
  • Growing demand for gene therapy
  • Increase in vaccine development
FUTURE TRENDS
  • Development of automated manufacturing platforms
  • Use of synthetic biology in production
OPPORTUNITIES
  • Expansion in biotech and pharmaceutical industries
  • Growth in cancer immunotherapy

Key Players

  • Brammer Bio
  • Sanofi
  • FUJIFILM Diosynth Biotechnologies
  • Cell and Gene Therapy Catapult
  • Cobra Biologics
  • FinVector
  • Kaneka Eurogentec S A
  • MassBiologics
  • Spark Therapeutics

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Product
  • Viral Vectors and Non-viral Vectors
Application
  • Cancer
  • Inherited Disorders
  • Viral Infections